Results 261 to 270 of about 158,411 (308)
Some of the next articles are maybe not open access.
Anticoagulant therapy in pregnancy
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1999Anticoagulation during pregnancy should derive benefit from recent advances in anticoagulant therapy. Unfractionated heparin is at present the drug of choice for most of the indications of thromboprophylaxis as well as for acute venous thrombosis during pregnancy but it is likely that, in the near future, low molecular weight heparins will supercede ...
F, Robin +4 more
openaire +2 more sources
The Management of Anticoagulant Therapy
Postgraduate Medicine, 1960Safe, effective anticoagulant therapy requires observance of certain principles of management. The physician must be certain that an absolute contraindication to such therapy does not exist, must be familiar with the agents employed, and must know how to reverse their effects promptly.
P W, WILLIS, W W, COON, I F, DUFF
openaire +2 more sources
An Evaluation of Anticoagulant Therapy
Cardiology, 1952Abstract 1.1. During the past decade the indications for anticoagulant therapy have been clarified. They are listed herein. 2.2. In view of the reduction in both death rate and in the incidence of thromboembolic complications following coronary thrombosis with myocardial infarction with the use of anticoagulants in mild and moderately severe cases,
openaire +3 more sources
Anticoagulant therapy in practice
Orvosi Hetilap, 2012Atrial fibrillation is a risk factor for ischemic stroke. To prevent stroke oral anticoagulants can be administered. Old and new types of anticoagulants are available. Nowadays, old type, acenocumarol based anticoagulants are used preferentially in Hungary.
Gergely, Hofgárt +2 more
openaire +2 more sources
Development in anticoagulant therapy
Critical Reviews in Oncology/Hematology, 2008Venous thromboembolism is an important clinical problem. Cancer patients have higher risk to develop venous thrombosis and vice versa. The treatment consists of heparin followed by vitamin K antagonists. Both agents have several limitations. Especially in cancer patients, vitamin K antagonists cause bleeding or recurrence of VTE because of a small ...
F F, van Doormaal +2 more
openaire +2 more sources
Anticoagulation Therapy in Children
Seminars in Thrombosis and Hemostasis, 2017AbstractVenous thromboembolism (VTE) is very uncommon in children and adolescents compared with older adults, though its incidence has significantly increased over the past two decades. Given the rarity of the condition, the data on pediatric VTE lag behind the adult experience and consequently the management of VTE in children is, in large part ...
openaire +2 more sources
Indications for Anticoagulant Therapy
New England Journal of Medicine, 1963THE place of anticoagulant therapy in the various types and phases of occlusive vascular disease, venous and arterial, has been debated ever since its introduction into clinical practice more than fifteen years ago. The widely divergent opinions and seemingly conflicting results of therapeutic trials that have appeared are unmistakable symptoms of ...
openaire +3 more sources
Pharmacogenetics and Anticoagulant Therapy
Journal of Thrombosis and Thrombolysis, 2003Warfarin and other coumarins are metabolized by the cytochrome P450 2C9 complex. Common single-nucleotide polymorphisms (SNPs) in this enzyme are associated with an exaggerated elevation in the INR during warfarin initiation and an increased risk of bleeding. These observations suggest that patients known to carry the putative SNPs should be started on
Brian F, Gage, Charles S, Eby
openaire +2 more sources
Current Opinion in Hematology, 1996
Oral anticoagulant therapy is effective antithrombotic treatment for several indications. The results of prothrombin time monitoring should be reported as the International Normalized Ratio (INR). An INR of 2 to 3 is the recommended therapeutic range for all indications except for the prevention of systemic embolism in patients with mechanical heart ...
openaire +2 more sources
Oral anticoagulant therapy is effective antithrombotic treatment for several indications. The results of prothrombin time monitoring should be reported as the International Normalized Ratio (INR). An INR of 2 to 3 is the recommended therapeutic range for all indications except for the prevention of systemic embolism in patients with mechanical heart ...
openaire +2 more sources
Indications for anticoagulant therapy
American Heart Journal, 1969Abstract The value of anticoagulant therapy is solidly established in the presence of deepvein thrombosis and pulmonary embolism, in the presence of recurrent cerebral ischemic episodes when reparative vascular surgery is not possible, and in postoperative and bedridden patients, at least those with a high risk of pulmonary embolism.
A F, Lyon, A C, DeGraff
openaire +2 more sources